Scientists test new skin Drug's hidden effects on birth control and blood thinners
NCT ID NCT07190430
Summary
This early-stage study aims to understand how an experimental atopic dermatitis (eczema) medication called PF-08049820 affects how the body processes three common drugs: birth control pills, a sedative (midazolam), and a blood thinner (dabigatran). Researchers will enroll 16 healthy adult women to first take each common drug alone, then take them alongside the new medication to measure any changes. The goal is to gather safety information to help design future studies, not to treat eczema in this trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.